Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 6/2011

01.12.2011 | Commentary

Medication management during pregnancy: role of the pharmacist

verfasst von: Nardin Samuel, Adrienne Einarson

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

A community pharmacist is frequently the first healthcare professional who is asked to give advice regarding medication use during pregnancy. As 50% of pregnancies are unplanned, a woman often discovers she is pregnant while already taking a medication and visits a pharmacy which is easily accessible, to enquire if she has harmed her baby by this action. Following a review of the literature, of which there is a paucity on this topic, we found that pharmacists often do not feel equipped to dispense teratology information and frequently refer the woman to her attending physician, without giving any information. In addition, it was clear that even when they did give information, it was not necessarily evidence-based and at times, inaccurate and based on their own opinions. In this article, we have attempted to make pharmacists aware of all the sources that are available, to enable them to perform this important role as a member of the health care team. These include websites, texts, evidence-based literature, teratogen information services and more. With the knowledge extracted from various resources, following critical appraisal of the data, they should be more comfortable and feel better equipped to transfer this information to a pregnant woman. In conclusion, while there may be a lack of adequate information regarding use of certain medications during pregnancy, pharmacists should be able to integrate available information with their medication expertise, to make appropriate individual risk/benefit decisions. This requires active engagement with pregnant women, rather than automatically referring them to their physician, thus establishing the pharmacist role as an essential member of the health care team.
Literatur
1.
Zurück zum Zitat Nordeng H, Ystrøm E, Einarson A. Perception of risk regarding the use of medications and other exposures during pregnancy. Eur J Clin Pharmacol. 2010;66:207–14.PubMedCrossRef Nordeng H, Ystrøm E, Einarson A. Perception of risk regarding the use of medications and other exposures during pregnancy. Eur J Clin Pharmacol. 2010;66:207–14.PubMedCrossRef
2.
Zurück zum Zitat Bradley CP. The future role of pharmacists in primary care. Br J Gen Pract. 2009;59(569):891–2.PubMedCrossRef Bradley CP. The future role of pharmacists in primary care. Br J Gen Pract. 2009;59(569):891–2.PubMedCrossRef
3.
Zurück zum Zitat Lyszkiewicz D, Gerichhausen S, Björnsdóttir I, Einarson TR, Koren G, Einarson A. Evidencebased information on drug use during pregnancy: a survey of community pharmacists in three countries. Pharm World Sci. 2001;23:76–81.PubMedCrossRef Lyszkiewicz D, Gerichhausen S, Björnsdóttir I, Einarson TR, Koren G, Einarson A. Evidencebased information on drug use during pregnancy: a survey of community pharmacists in three countries. Pharm World Sci. 2001;23:76–81.PubMedCrossRef
4.
Zurück zum Zitat Einarson A, Mazzieri MR, Sola NH, Einarson TR, The Cordoba Pharmacy Practice Research Group. Evidence based information on drug use during pregnancy: assessment of community pharmacists in Cordoba, Argentina. Pharmaceutical Care (España). 2002;4:209–21. Einarson A, Mazzieri MR, Sola NH, Einarson TR, The Cordoba Pharmacy Practice Research Group. Evidence based information on drug use during pregnancy: assessment of community pharmacists in Cordoba, Argentina. Pharmaceutical Care (España). 2002;4:209–21.
5.
Zurück zum Zitat Vanham D, Spinewine A. Evaluation of the quality of counselling provided by community pharmacists to pregnant women. J Pharm Belg 2010; (3):68–74. Vanham D, Spinewine A. Evaluation of the quality of counselling provided by community pharmacists to pregnant women. J Pharm Belg 2010; (3):68–74.
6.
Zurück zum Zitat Damase-Michel C, Vie C, Lacroix I, Lapeyre-Mestre M, Montastruc JL. Drug counselling in pregnancy: an opinion survey of French community pharmacists. Pharmacoepidemiol Drug Safety. 2004;13:711–5.CrossRef Damase-Michel C, Vie C, Lacroix I, Lapeyre-Mestre M, Montastruc JL. Drug counselling in pregnancy: an opinion survey of French community pharmacists. Pharmacoepidemiol Drug Safety. 2004;13:711–5.CrossRef
7.
Zurück zum Zitat Cohen LS, Wang B, Nonacs R, Viguera AC, Lemon EL, Freeman MP. Treatment of mood disorders during pregnancy, postpartum. Psychiatr Clin North Am. 2010;33(2):273–93.PubMedCrossRef Cohen LS, Wang B, Nonacs R, Viguera AC, Lemon EL, Freeman MP. Treatment of mood disorders during pregnancy, postpartum. Psychiatr Clin North Am. 2010;33(2):273–93.PubMedCrossRef
8.
Zurück zum Zitat Damase-Michel C, Christaud J, Berrebi A, Lacroix I, Montastruc JL. What do pregnant women know about non-steroidal anti-inflammatory drugs? Pharmacoepidemiol Drug Safety. 2009;18:1034–8.CrossRef Damase-Michel C, Christaud J, Berrebi A, Lacroix I, Montastruc JL. What do pregnant women know about non-steroidal anti-inflammatory drugs? Pharmacoepidemiol Drug Safety. 2009;18:1034–8.CrossRef
9.
Zurück zum Zitat Jentink J, Dolk H, Loane MA, Morris JK, Wellesley D, Garne E, de Jong-van den Berg L; EUROCAT Antiepileptic Study Working Group. Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study. BMJ. 2010; 341:c6581. doi:10.1136/bmj.c6581. Review. Jentink J, Dolk H, Loane MA, Morris JK, Wellesley D, Garne E, de Jong-van den Berg L; EUROCAT Antiepileptic Study Working Group. Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study. BMJ. 2010; 341:c6581. doi:10.​1136/​bmj.​c6581. Review.
10.
Zurück zum Zitat Czeizel EA, Rockenbauer M, Sorensen HT, Olsen J. Nitrofurantoin and congenital abnormalities. Eur J Obstet Gynecol Reprod Biol. 2001;95:119–26.PubMedCrossRef Czeizel EA, Rockenbauer M, Sorensen HT, Olsen J. Nitrofurantoin and congenital abnormalities. Eur J Obstet Gynecol Reprod Biol. 2001;95:119–26.PubMedCrossRef
11.
Zurück zum Zitat Ben David S, Einarson T, Ben David Y, Nulman I, Pastuszak A, Koren G. The safety of nitrofurantoin during the first trimester of pregnancy: meta-analysis. Fundam Clin Pharmacol. 1995;9:503–7.PubMedCrossRef Ben David S, Einarson T, Ben David Y, Nulman I, Pastuszak A, Koren G. The safety of nitrofurantoin during the first trimester of pregnancy: meta-analysis. Fundam Clin Pharmacol. 1995;9:503–7.PubMedCrossRef
12.
Zurück zum Zitat Gait JE. Hemolytic reactions to nitrofurnatoin in patients with glucose-6-phasephate dehydrogenase deficiency: theory and practice. DICP Ann Pharmacother. 1990;24:1210–3. Gait JE. Hemolytic reactions to nitrofurnatoin in patients with glucose-6-phasephate dehydrogenase deficiency: theory and practice. DICP Ann Pharmacother. 1990;24:1210–3.
13.
Zurück zum Zitat Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health. 2006;38(2):90–6.PubMedCrossRef Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health. 2006;38(2):90–6.PubMedCrossRef
15.
Zurück zum Zitat [No authors listed]. Pregnancy labeling. FDA Drug Bull. 1979; 9(4):23–4. [No authors listed]. Pregnancy labeling. FDA Drug Bull. 1979; 9(4):23–4.
16.
Zurück zum Zitat Feibus KB. FDA’s proposed rule for pregnancy and lactation labelling: improving maternal child health through well-informed medicine use. J Med Toxicol. 2008;4(4):284–8.PubMedCrossRef Feibus KB. FDA’s proposed rule for pregnancy and lactation labelling: improving maternal child health through well-informed medicine use. J Med Toxicol. 2008;4(4):284–8.PubMedCrossRef
17.
Zurück zum Zitat Einarson A. Antidepressants and pregnancy: complexities of producing evidence-based information. CMAJ. 2010;182(10):1017–8.PubMedCrossRef Einarson A. Antidepressants and pregnancy: complexities of producing evidence-based information. CMAJ. 2010;182(10):1017–8.PubMedCrossRef
20.
Zurück zum Zitat Briggs CG. Drugs in pregnancy and lactation. 9th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2011. Briggs CG. Drugs in pregnancy and lactation. 9th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2011.
Metadaten
Titel
Medication management during pregnancy: role of the pharmacist
verfasst von
Nardin Samuel
Adrienne Einarson
Publikationsdatum
01.12.2011
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 6/2011
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-011-9560-8

Weitere Artikel der Ausgabe 6/2011

International Journal of Clinical Pharmacy 6/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.